Golden Ally Lifetech Group, Inc.
AQPW · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $17 | $17 | $17 | $6 |
| Gross Profit | -$17 | -$17 | -$17 | -$6 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $80 | $0 | $0 |
| G&A Expenses | $2,426 | $1,007 | $1,418 | $1,580 |
| SG&A Expenses | $2,426 | $1,007 | $1,418 | $1,580 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1,753 | $438 | $6 |
| Operating Expenses | $2,428 | $1,087 | $1,418 | $1,585 |
| Operating Income | -$2,428 | -$1,087 | -$1,418 | -$1,586 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$1 |
| Pre-Tax Income | -$2,428 | -$1,087 | -$1,418 | -$1,586 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,428 | -$1,088 | -$1,418 | -$1,585 |
| % Margin | – | – | – | – |
| EPS | -0.033 | -0.015 | -0.017 | -0.02 |
| % Growth | -123.1% | 12% | 16.5% | – |
| EPS Diluted | -0.033 | -0.015 | -0.017 | -0.02 |
| Weighted Avg Shares Out | 74,065 | 74,036 | 84,755 | 79,372 |
| Weighted Avg Shares Out Dil | 74,065 | 74,036 | 84,755 | 79,372 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $17 | $17 | $17 | $7 |
| EBITDA | -$2,410 | -$1,069 | -$1,401 | -$1,580 |
| % Margin | – | – | – | – |